Form 8-K - Current report:
SEC Accession No. 0001213900-21-035662
Filing Date
2021-07-06
Accepted
2021-07-06 07:00:27
Documents
3
Period of Report
2021-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea143716-8k_immucell.htm 8-K 27899
2 NOTE PURCHASE AGREEMENT EXECUTED BY IMMUCELL CORPORATION IN FAVOR OF THE MAINE T ea143716ex99-1_immucell.htm EX-99.1 96243
3 SUBORDINATED PROMISSORY NOTE FOR $400,000 EXECUTED BY IMMUCELL CORPORATION IN FA ea143716ex99-2_immucell.htm EX-99.2 39465
  Complete submission text file 0001213900-21-035662.txt   164827
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 211072461
SIC: 2835 In Vitro & In Vivo Diagnostic Substances